Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1996-09-16
1999-09-14
Caputa, Anthony C.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
4241841, 42419711, 4242341, 4242351, 4242411, 4242491, 4242551, 4242561, 4242571, 4242581, 4242601, 4242611, 514 54, 536123, 5361231, 536127, 536 111, A61K 3910, A61K 3902
Patent
active
059519878
ABSTRACT:
A vaccine comprising purified outer-polysaccharide (OPS) is effective for protection against brucellosis. The vaccine is derived from Brucella or a variety of cross reactive bacteria. The vaccine can be administered by different routes (intramuscularly, subcutaneously, intraperitoneally, orally). The vaccine is effective in protecting against other infectious bacteria, aside from Brucella. It is likely that the vaccine can be given after infection to reduce illness.
REFERENCES:
patent: 4707543 (1987-11-01), Zollinger et al.
patent: 4831126 (1989-05-01), Bundle et al.
patent: 5006463 (1991-04-01), Cherwonogrodzky et al.
patent: 5225194 (1993-07-01), Suer
"Antigens of Brucella" by J. Cherwonogrodzky et al, pp. 19-64, In: K. Nielsen, J.R. Duncan (ed.) 1990 Animal Brucellosis CRC Press, Boca Raton mentioned on p. 4 of the application.
"Sensitive fluorogenic enzyme immunoassay on nitrocellulose membranes for quantitation of virus" by Roberta E. Fulton et al, Jrn. of Virological Methods, 22 (1988) pp. 149 to 164 (mentioned on p. 7 of the application).
"Laboratory Animal Models for Brucellosis Studies" by Casimiro Garcia-Carrillo pp. 423 to 442, In: K Nielsen, J.R. Duncan (ed) 1990 Animal Brucellosis (mentioned on p. 9 of the application).
"The Pathogenesis and Pathobiology of Brucella Infection in Domestic Animals" by Fred M. Enright, pp. 301 to 320, In: K. Nielsen, J.R. Duncan (ed.) 1990 Animal Brucellosis (mentioned on p. 14 of the application).
"Radial Immunodiffusion Test with a Brucella Polysaccharide Antigen for Differentiating Infected from Vaccinated Cattle" by Ramon Diaz et al, pp. 37 to 41 in Jrn. of Clinical Microbiology, Jul. 1979 (mentioned on p. 14 of the application).
P. Nicoletti et al. "The Immune response to B. Abortus: . . . " Animal Brucellosis, Chapter 4, pp. 83-95, 1990.
L. Corbeil et al. "Killing of Brucella abortus by bovine serum" Infection and Immunity, Dec. 1988, vol. 56, No. 12, pp. 3251-3261.
Wong et al (1992) Immunology. vol. 77, 123-128.
Stevens et al (1995) Infect. & Immunity. vol. 63(1), 264-270.
Cherwonogrodzky John W.
Di Ninno Vincent L.
Wong Jonathan P.
Caputa Anthony C.
Her Majesty the Queen as represented by the Minister of National
Masood Khalid
LandOfFree
Polysaccharide vaccine to enhance immunity against brucellosis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polysaccharide vaccine to enhance immunity against brucellosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polysaccharide vaccine to enhance immunity against brucellosis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1507992